top of page


From Box Ticking to Regulatory Readiness: Reflections from the Cork Biopharma Forum
On paper, most organisations can point to a Contamination Control Strategy, supported by procedures and risk assessments, with clear links into the quality system. From a distance, the framework looks sound. The challenge usually appears later, when inspectors stop reviewing documents and start asking people to explain how contamination risks are actually controlled day to day. At that point, even well-established systems can begin to feel fragile. This is not a skills gap. I
-
Feb 64 min read


Vendor Oversight 101 for Cosmetics: Building a Compliant, Resilient Supply Chain
In cosmetics, product safety starts long before a product is opened. The integrity of your raw materials, packaging, and contracted operations determines whether your Product Information File (PIF) and Cosmetic Product Safety Report (CPSR) stand up to scrutiny, and whether your brand can move quickly without compliance surprises. Under Regulation (EC) No. 1223/2009, the Responsible Person (RP) remains accountable for safety, GMP, and market compliance, even when activities ar
-
Jan 294 min read


Ensuring Regulatory Standards in the Pharmaceutical Industry
Regulatory compliance is the backbone of trust and safety in the pharmaceutical industry. As global demand for medicines rises, so too does the responsibility of companies to meet rigorous standards that protect patients and maintain product quality. Compliance is not optional, it is a critical safeguard against risks that can compromise health, damage reputations, and result in costly enforcement actions. Communication Networks. What Pharmaceutical Compliance Means Pharmaceu
-
Jan 223 min read
bottom of page
